Health
KalVista Pharmaceuticals Inc. Seeks Global Approval for Hereditary Angioedema Treatment
KalVista Pharmaceuticals Pursuing Global Approval for Promising Hereditary Angioedema Therapy KalVista Pharmaceuticals Inc. announced a positive financial outlook for the future as they propel sebetralstat,
December 6, 2024
No Comments